Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / March 7, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avid Bioservices, Inc. ("Avid Bioservices" or "the Company") (NASDAQ:CDMO). Investors who purchased Avid Bioservices securities are encouraged to obtain...
2024-03-07 12:49:07 ET More on Mid-day movers & stocks. Financial information for Nature Wood Group Financial information for Psyence Biomedical Ltd. Read the full article on Seeking Alpha For further details see: PBM and NWGL among mid-day movers
2024-03-07 10:01:04 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...
2024-03-07 08:35:57 ET More on Pre-market losers & stocks. Rail Vision shares rally as Main Line System gets EU approval and certifications Rail Vision wins contract valued at up to $5 million, shares jump Financial information for Airship AI Holdings, Inc. ...
2024-03-07 08:05:19 ET More on Avid Bioservices Laughing Water Capital - Avid Bioservices: Substantial Future Earnings Power, Strong Competitive Position Avid Bioservices: Don't Miss The Bigger Picture Avid Bioservices says revenues for third quarter of fiscal 2024 w...
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today the pricing of $160 million aggregate principal amount of 7.00% Convertible Senior Notes due 2029 (the “...
2024-03-06 16:41:51 ET More on Avid Bioservices Laughing Water Capital - Avid Bioservices: Substantial Future Earnings Power, Strong Competitive Position Avid Bioservices: Don't Miss The Bigger Picture Avid Bioservices, Inc. (CDMO) Q2 2024 Earnings Call Transcript ...
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today that it intends to offer, subject to market conditions and other factors, $160 million aggregate principal amo...
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pha...
2024-02-14 14:11:46 ET More on Charles River, IQVIA, etc. Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript Medpace Holdings, Inc. (MEDP) Q4 2023 Earnings Call Transcript Medpace Holdings, Inc. 2023 Q4 - Results - Earnings Call Pre...
News, Short Squeeze, Breakout and More Instantly...
Avid Bioservices Inc. Company Name:
CDMO Stock Symbol:
NASDAQ Market:
Avid Bioservices Inc. Website:
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and Gene Therapy Facilities Fully Operational and in Service; Capital Expenditur...
China Yuchai International Limited (CYD) is expected to report for Q1 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Derwent London Plc (DWVYF) is expected to report for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Basilea Pharmaceutic...
TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announc...